| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |